Financhill
Back

Recursion Pharmaceuticals Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
72

RXRX
Recursion Pharmaceuticals

Last Price:
7.09
Seasonality Move:
18.05%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
43.34
Seasonality Move:
-15.89%
Buy
72
Recursion Pharmaceuticals (RXRX) is a Buy

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $7.07. The Score for RXRX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • RXRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $7.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $44.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 57.65 Buy
Chaikin Money Flow: 10857249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.06 - 7.14) Buy
Bollinger Bands (100): (6.19 - 7.59) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 58.93 Buy
Chaikin Money Flow: 115403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.12 - 49.42) Buy
Bollinger Bands (100): (-5.11 - 34.85) Buy

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.14 Buy
20-day SMA: 6.59 Buy
50-day SMA: 6.58 Buy
200-day SMA: 8.25 Sell
8-day EMA: 6.36 Buy
20-day EMA: 6.46 Buy
50-day EMA: 6.63 Buy
200-day EMA: 7.62 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.17 Buy
20-day SMA: 42.3 Buy
50-day SMA: 28.61 Buy
200-day SMA: 8.06 Buy
8-day EMA: 39.27 Buy
20-day EMA: 39.13 Buy
50-day EMA: 31.07 Buy
200-day EMA: 12.97 Buy

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):